PremiumCompany AnnouncementsLilly’s Lepodisiran Trial Targets Lp(a) as a New Front in Heart Risk2d agoLLY
PremiumCompany AnnouncementsRetatrutide Trial Completion Signals Next Step for Eli Lilly’s Diabetes Pipeline2d agoLLY
PremiumCompany AnnouncementsEli Lilly’s Mevidalen Alzheimer’s Trial Reaches Completion: What Investors Should Watch2d agoLLY